(P-547) Efficacy and Safety of B/F/TAF in Treatment-Naïve People With HIV Aged ≥ 50 Years: 5-Year Follow-Up From Two Phase 3 Studies

Executive Director
Joint clinical Research Center
Kampala, Luuka, Uganda

Professor of Medicine
Indiana University School of Medicine
Indianapolis, Indiana, United States

Professor, Medicine; Chief, Division of Infectious Diseases and Travel Medicine
Georgetown University Medical Center, Washington, DC, USA
Washington, District of Columbia, United States

Senior Director
Gilead Sciences, Inc.
Foster City, California, United States

Gilead Sciences, Inc.
Foster City, California, United States

Director
Gilead Sciences, Inc.
Foster City, California, United States

Gilead Sciences
Foster City, California, United States

Prof
Department for Internal Medicine I, University Hospital of Bonn, Bonn, Germany
Bonn, Nordrhein-Westfalen, Germany